secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensus Healthcare, Inc. (SRTS)
CIK:        0001494891
Form:       8-K
Filed at:   2022-01-05T23:59:59+00:00
Accession:  0001213900-22-000684
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensus Healthcare expects record Q4 2021 sales over $25M, profitable Q4 and FY
------------------------------------------------------------------------------

- Expects record Q4 sales; full-year 2021 revenue over $25M.
- Expects positive EBITDA and net income for Q4 and full year.
- Q4 sales include three SRT systems shipped to China.
- Also expects profitability for Q1 2022.
- TransDermal Infusion System featured at Winter Clinical Dermatology Conference on Jan 15.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1494891/000121390022000684/0001213900-22-000684-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1494891/000121390022000684/ea153545-8k_sensushealth.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-000684

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer